BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 22619086)

  • 1. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.
    Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR
    Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection.
    Byrne DD; Newcomb CW; Carbonari DM; Nezamzadeh MS; Leidl KB; Herlim M; Yang YX; Hennessy S; Kostman JR; Leonard MB; Localio AR; Lo Re V
    J Viral Hepat; 2015 Nov; 22(11):936-47. PubMed ID: 25754215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.
    Lo Re V; Kallan MJ; Tate JP; Localio AR; Lim JK; Goetz MB; Klein MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Park L; Dubrow R; Reddy KR; Kostman JR; Strom BL; Justice AC
    Ann Intern Med; 2014 Mar; 160(6):369-79. PubMed ID: 24723077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
    Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L;
    J Hepatol; 2021 Jan; 74(1):37-47. PubMed ID: 32798585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis and fractures in HIV/hepatitis C virus coinfection: a systematic review and meta-analysis.
    Dong HV; Cortés YI; Shiau S; Yin MT
    AIDS; 2014 Sep; 28(14):2119-31. PubMed ID: 24977441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status.
    Byrne DD; Tate JP; Forde KA; Lim JK; Goetz MB; Rimland D; Rodriguez-Barradas MC; Butt AA; Gibert CL; Brown ST; Bedimo R; Freiberg MS; Justice AC; Kostman JR; Roy JA; Lo Re V
    Clin Infect Dis; 2017 Oct; 65(9):1542-1550. PubMed ID: 29020184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.
    Ogdie A; Pang WG; Forde KA; Samir BD; Mulugeta L; Chang KM; Kaplan DE; Amorosa VK; Kostman JR; Reddy RK; Schumacher RH; Lo Re V
    BMC Musculoskelet Disord; 2015 Apr; 16():93. PubMed ID: 25896674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.
    Kruse RL; Kramer JR; Tyson GL; Duan Z; Chen L; El-Serag HB; Kanwal F
    Hepatology; 2014 Dec; 60(6):1871-8. PubMed ID: 25065513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of hip fracture associated with untreated and treated chronic hepatitis B virus infection.
    Byrne DD; Newcomb CW; Carbonari DM; Nezamzadeh MS; Leidl KB; Herlim M; Yang YX; Hennessy S; Kostman JR; Leonard MB; Localio AR; Lo Re V
    J Hepatol; 2014 Aug; 61(2):210-8. PubMed ID: 24713185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort.
    Quaranta MG; Ferrigno L; Monti M; Filomia R; Biliotti E; Iannone A; Migliorino G; Coco B; Morisco F; Vinci M; D'Ambrosio R; Chemello L; Massari M; Ieluzzi D; Russo FP; Blanc P; Verucchi G; Puoti M; Rumi MG; Barbaro F; Santantonio TA; Federico A; Chessa L; Gentile I; Zuin M; Parruti G; Morsica G; Kondili LA;
    Hepatol Int; 2020 May; 14(3):362-372. PubMed ID: 32279177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Differential Effects of Human Immunodeficiency Virus and Hepatitis C Virus on Bone Microarchitecture and Fracture Risk.
    Bedimo RJ; Adams-Huet B; Poindexter J; Brown G; Farukhi I; Castanon R; Turner D; Moore T; Tebas P; Maalouf NM
    Clin Infect Dis; 2018 Apr; 66(9):1442-1447. PubMed ID: 29145609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.
    Kramer JR; Kowalkowski MA; Duan Z; Chiao EY
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):456-62. PubMed ID: 25559606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
    Lo Re V; Zeldow B; Kallan MJ; Tate JP; Carbonari DM; Hennessy S; Kostman JR; Lim JK; Goetz MB; Gross R; Justice AC; Roy JA
    Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1172-1181. PubMed ID: 28722244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study.
    Seyoum E; Demissie M; Worku A; Mihret A; Abdissa A; Berhane Y
    BMC Public Health; 2022 Apr; 22(1):644. PubMed ID: 35379215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.
    Sangal RB; Taylor LE; Gillani F; Poppas A; Klinger JR; Ventetuolo CE
    Ann Am Thorac Soc; 2014 Dec; 11(10):1553-9. PubMed ID: 25375659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased incidence of cancer observed in HIV/hepatitis C virus-coinfected patients versus HIV-monoinfected.
    Meijide H; Pértega S; Rodríguez-Osorio I; Castro-Iglesias Á; Baliñas J; Rodríguez-Martínez G; Mena Á; Poveda E
    AIDS; 2017 May; 31(8):1099-1107. PubMed ID: 28441174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals.
    Shuper PA; Joharchi N; Irving H; Fletcher D; Kovacs C; Loutfy M; Walmsley SL; Wong DK; Rehm J
    AIDS Care; 2016 Aug; 28(8):954-62. PubMed ID: 26971360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of serum albumin and aspartate transaminase with 5-year all-cause mortality in HIV/hepatitis C virus coinfection and HIV monoinfection.
    Scherzer R; Heymsfield SB; Rimland D; Powderly WG; Tien PC; Bacchetti P; Shlipak MG; Grunfeld C;
    AIDS; 2017 Jan; 31(1):71-79. PubMed ID: 27677166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.